Managers / Q4 2025
MWG Caph LtdNEW FILER
CIK 0002111120 · MORTON HOUSE, GOVERNMENT ROAD, PO BOX 583, CHARLESTOWN, NEV 0001 · 212-804-9040
Summary
Mwg Caph Ltd reported $72M in U.S.-listed holdings across 3 positions for Q4 2025.
The portfolio is heavily concentrated: BEAM alone accounts for 48.5% of reported value.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $72M
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BEAMBEAM THERAPEUTICS INC | NEW | +1.27M | 1.27M | +$35M | $35M |
| LYELLYELL IMMUNOPHARMA INC | NEW | +1.01M | 1.01M | +$31M | $31M |
| PRMEPRIME MEDICINE INC | NEW | +1.79M | 1.79M | +$6M | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | BEAMBEAM THERAPEUTICS INChistory → | COM | 48.53% | $35M | 1.27M |
| 2 | LYELLYELL IMMUNOPHARMA INChistory → | COM NEW | 42.88% | $31M | 1.01M |
| 3 | PRMEPRIME MEDICINE INChistory → | COM | 8.59% | $6M | 1.79M |
Filing History
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Milky Way Investments Group Ltd.028-21023
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.